{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T11:31:15Z","timestamp":1694086275149},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1086\/314069","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:58:36Z","timestamp":1027709916000},"page":"S101-S105","source":"Crossref","is-referenced-by-count":3,"title":["Reduction of Side Effects of Intravesical Therapy with Bacille Calmette-Gu\u00e9rin by Pentoxifylline?\u2014An In Vitro Approach"],"prefix":"10.1093","volume":"31","author":[{"given":"A.","family":"B\u00f6hle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thanh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-D.","family":"Flad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"R\u00fcsch-Gerdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jocham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,9]]},"reference":[{"key":"key\n\t\t\t\t20171014042638_R1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0952-7915(93)90128-F","article-title":"Non-antibody immunotherapy of cancer","volume":"5","author":"Chapman","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t20171014042638_R2","first-page":"643","article-title":"BCG therapy for superficial bladder cancer: fundamental aspects","volume":"5","author":"Hudson","year":"1991","journal-title":"In Vivo"},{"key":"key\n\t\t\t\t20171014042638_R3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0094-0143(21)00424-9","article-title":"Long-term results of intravesical therapy for superficial bladder cancer","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin N Am"},{"key":"key\n\t\t\t\t20171014042638_R4","first-page":"499","article-title":"Carcinoma in situ","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin N Am"},{"key":"key\n\t\t\t\t20171014042638_R5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)38242-3","article-title":"Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Gu\u00e9rin","volume":"145","author":"Herr","year":"1991","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000473593","article-title":"Local BCG failures in superficial bladder cancer: a multivariate analysis of risk factors influencing survival","volume":"19","author":"Herr","year":"1991","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20171014042638_R7","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"Calmette-Gu\u00e9rin therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171014042638_R8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-0143(21)00422-5","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy: techniques and results","volume":"19","author":"Brosman","year":"1992","journal-title":"Urol Clin N Am"},{"key":"key\n\t\t\t\t20171014042638_R9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0094-0143(21)00423-7","article-title":"Complications of bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin N Am"},{"key":"key\n\t\t\t\t20171014042638_R10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(17)39365-5","article-title":"Effects of local bacillus Calmette-Gu\u00e9rin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall","volume":"144","author":"B\u00f6hle","year":"1990","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R12","first-page":"199","article-title":"Long-term immunobiological effects of intravesical bacillus Calmette-Gu\u00e9rin against bladder carcinoma recurrences","volume-title":"Developments in biological standardization: standardization of the immunopharmacology of natural and synthetic immunomodulators","author":"B\u00f6hle","year":"1992"},{"key":"key\n\t\t\t\t20171014042638_R13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/1043-4666(90)90013-J","article-title":"Detection of urinary TNF, IL 1, and IL 2 after local BCG immunotherapy for bladder carcinoma","volume":"2","author":"B\u00f6hle","year":"1990","journal-title":"Cytokine"},{"key":"key\n\t\t\t\t20171014042638_R14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"34","author":"de Boer","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014042638_R15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0022-5347(17)45142-1","article-title":"Detection of interleukin-2 in the urine of patients with superficial bladder tumors after treatment with intravesical bacillus Calmette-Gu\u00e9rin","volume":"136","author":"Haaff","year":"1986","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(89)92929-2","article-title":"Oxpentifylline in endotoxaemia","volume":"30","author":"Zabel","year":"1989","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014042638_R17","first-page":"80","article-title":"Pentoxifyllin\u2014ein Synthesehemmer f\u00fcr Tumor-Nekrose-Faktor-\u03b1","volume":"20","author":"Zabel","year":"1992","journal-title":"Immun Infekt"},{"key":"key\n\t\t\t\t20171014042638_R18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00007890-199110000-00018","article-title":"Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome","volume":"52","author":"Alegre","year":"1991","journal-title":"Transplant"},{"key":"key\n\t\t\t\t20171014042638_R19","first-page":"207","article-title":"Effects of pentoxifylline in endotoxinemia in human volunteers","volume":"367","author":"Zabel","year":"1991","journal-title":"Prog Clin Biol Res"},{"key":"key\n\t\t\t\t20171014042638_R20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01517042","article-title":"Induction of bacillus Calmette-Gu\u00e9rin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro","volume":"37","author":"Thanh\u00e4user","year":"1993","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014042638_R21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0171-2985(89)80036-1","article-title":"Induction of tumor necrosis factor-\u03b1 release by lipopolysaccharide and defined lipopolysaccharide partial structures","volume":"179","author":"Feist","year":"1989","journal-title":"Immunobiol"},{"key":"key\n\t\t\t\t20171014042638_R22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0171-2985(89)80004-X","article-title":"The effect of interleukin-2 on FC-\u03b3 receptor function of human monocytes requires specific intercellular interaction","volume":"179","author":"Ennen","year":"1988","journal-title":"Immunobiol"},{"key":"key\n\t\t\t\t20171014042638_R23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0022-5347(17)35941-4","article-title":"Dissecting the immunobiological effects of bacillus Calmette-Gu\u00e9rin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon","volume":"150","author":"B\u00f6hle","year":"1993","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R24","first-page":"967","article-title":"Untersuchungen mit dem System Bactec 460. Empfindlichkeitspr\u00fcfung bei Mycobacterium tuberculosis. Vergleich der randiometrischen mit der konventionellen Methode","volume":"39","author":"R\u00fcsch-Gerdes","year":"1985","journal-title":"Prax Klin Pneumol"},{"key":"key\n\t\t\t\t20171014042638_R25","first-page":"219","article-title":"Untersuchungen mit dem system Bactec 460. 2. Isolierung von Mycobacterium tuberculosis aus sputum: vergleich der radiometrischen mit der konventionellen methode","volume":"41","author":"R\u00fcsch-Gerdes","year":"1987","journal-title":"Prax Klin Pneumol"},{"key":"key\n\t\t\t\t20171014042638_R26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacillus Calmette-Gu\u00e9rin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014042638_R27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance BCG immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized prospective Southwest Oncology Group study [abstract]","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R29","first-page":"108","article-title":"Alpha-interferon and interleukin-2 in renal cell carcinoma. studies in nonhospitalized patients","volume":"5","author":"Atzpodien","year":"1991","journal-title":"Semin Oncol"},{"key":"key\n\t\t\t\t20171014042638_R30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-5347(17)39366-7","article-title":"Elevations of cytokines, interleukin-1, interleukin-2, and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"144","author":"B\u00f6hle","year":"1990","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00571848","article-title":"On the mode of action of intravesical bacillus Calmette-Gu\u00e9rin: in-vitro characterization of BCG-activated killer cells","volume":"22","author":"B\u00f6hle","year":"1994","journal-title":"Urol Res"},{"key":"key\n\t\t\t\t20171014042638_R32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0022-5347(17)36973-2","article-title":"Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig","volume":"148","author":"de Boer","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00571847","article-title":"Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer","volume":"22","author":"Stassar","year":"1994","journal-title":"Urol Res"},{"key":"key\n\t\t\t\t20171014042638_R34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-642-75972-7_21","article-title":"In vitro cellular cytotoxicity against human bladder carcinoma cell lines","volume-title":"Investigative urology 4","author":"B\u00f6hle","year":"1991"},{"key":"key\n\t\t\t\t20171014042638_R35","first-page":"2754","article-title":"Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture","volume":"36","author":"Herr","year":"1976","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014042638_R36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/1097-0142(19830815)52:4<667::AID-CNCR2820520417>3.0.CO;2-C","article-title":"Clinical application of a whole blood assay for human natural killer (NK) cell activity","volume":"52","author":"Morales","year":"1983","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171014042638_R37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-3083.1993.tb01720.x","article-title":"Specific activation of human peripheral blood \u03b3\/\u03b4+T lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines","volume":"38","author":"Wang","year":"1993","journal-title":"Scand J Immunol"},{"key":"key\n\t\t\t\t20171014042638_R38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-2478(91)90150-9","article-title":"Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines","volume":"27","author":"Wang","year":"1991","journal-title":"Immunol Letters"},{"key":"key\n\t\t\t\t20171014042638_R39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(17)46976-X","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer: effect of bacillus Calmette-Gu\u00e9rin viability on treatment results","volume":"134","author":"Kelley","year":"1985","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014042638_R40","first-page":"481","article-title":"Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability","volume":"38","author":"Brown","year":"1979","journal-title":"Immunol"},{"key":"key\n\t\t\t\t20171014042638_R41","first-page":"1611","article-title":"Reduction of bladder tumor growth in mice treated with intravesical bacillus Calmette-Gu\u00e9rin and its correlation with bacillus Calmette-Gu\u00e9rin viability and natural killer cell activity","volume":"43","author":"Shapiro","year":"1983","journal-title":"Cancer Res"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/31\/Supplement_3\/S101\/20903086\/31-Supplement_3-S101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T08:53:07Z","timestamp":1621241587000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/31\/Supplement_3\/S101\/330727\/Reduction-of-Side-Effects-of-Intravesical-Therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":41,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2000,9]]},"published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1086\/314069","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,9]]},"published":{"date-parts":[[2000,9,1]]}}}